D, C., M, F., C, M., M, P., L, S., S, B., . . . A, D. (2025). Effect of body mass index on the timing of therapeutic drug monitoring-guided dalbavancin dosing in patients with osteoarticular infections. The Journal of antimicrobial chemotherapy, 80(6), 1726. https://doi.org/10.1093/jac/dkaf132
Chicago Style (17th ed.) CitationD, Cattaneo, et al. "Effect of Body Mass Index on the Timing of Therapeutic Drug Monitoring-guided Dalbavancin Dosing in Patients with Osteoarticular Infections." The Journal of Antimicrobial Chemotherapy 80, no. 6 (2025): 1726. https://doi.org/10.1093/jac/dkaf132.
MLA (9th ed.) CitationD, Cattaneo, et al. "Effect of Body Mass Index on the Timing of Therapeutic Drug Monitoring-guided Dalbavancin Dosing in Patients with Osteoarticular Infections." The Journal of Antimicrobial Chemotherapy, vol. 80, no. 6, 2025, p. 1726, https://doi.org/10.1093/jac/dkaf132.